Related Experiment Video
Updated: Jan 10, 2026

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
Published on: January 28, 2020
Interaction between coronary lesion complexity and coronary microvascular dysfunction in the prognosis of NSTEMI
Ping Lin1,2,3,4, Yuxuan Zhang1,2,3,4, Zining Chen1,2,3,4
1Department of Cardiology, The Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, 310009, China.
Background:
The prognostic value of the American College of Cardiology/American Heart Association (ACC/AHA) lesion classification in NSTEMI remains insufficiently investigated, especially regarding its interaction with coronary microvascular disease (CMD).
Methods:
In 2212 NSTEMI patients, we evaluated lesion complexity by applying the modified ACC/AHA classification system and then measured post-PCI angio-IMR. The primary endpoint was major adverse cardiovascular events (MACE) at 2 years.
Results:
Patients with complex lesions demonstrated substantially elevated 2-year MACE rates compared to those with simple lesions (13.5% vs 7.5%, P < 0.001). Lesion complexity independently predicted MACE [HR 1.48 (95% CI (1.09-2.00)), P = 0.011]. Notably, the addition of lesion classification to a model containing the GRACE score and other clinical factors significantly improved risk prediction [C-index 0.708 (95% CI (0.672-0.744)) vs 0.693 (95% CI (0.655-0.730)), P = 0.017)]. Among non-CMD patients, complex lesions were correlated with the higher MACE incidence (10.50% vs 6.20%, P = 0.002), whereas no significant difference was observed in CMD patients (37.80% vs 26.00%, P = 0.166). Notably, CMD showed a strong association with complex lesions [OR 1.74 (95% CI (1.22-2.48)), P = 0.002]. Mediation analysis indicated that CMD accounted for 17% of the total effect of lesion complexity on MACE [proportion of effect 0.17 (95% CI (0. 07-0.39)), P = 0.002].
Conclusions:
The American College of Cardiology/American Heart Association lesion classification effectively stratifies risk in non-ST-segment elevation myocardial infarction, particularly among patients without coronary microvascular disease. Coronary microvascular disease is independently associated with complex coronary lesions and mediates approximately 17% of their adverse prognostic impact on major adverse cardiovascular events.
More Related Videos
Related Concept Videos
Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Acute Coronary Syndrome III: Diagnostic Studies
Coronary Artery Disease II: Pathophysiology
Acute Coronary Syndrome IV: Interprofessional Care
Coronary Artery Disease III: Clinical Manifestations

